These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 3132638

  • 21. Effects of protease therapy in the remnant kidney model of progressive renal failure.
    Sebekova K, Paczek L, Dämmrich J, Ling H, Spustova V, Gaciong Z, Heidland A.
    Miner Electrolyte Metab; 1997; 23(3-6):291-5. PubMed ID: 9387136
    [Abstract] [Full Text] [Related]

  • 22. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [Abstract] [Full Text] [Related]

  • 23. Effect of antihypertensive therapy in experimental chronic renal failure.
    Wight JP, Bassett AH, Hutchesson A, Thurrell W, el Nahas AM.
    Miner Electrolyte Metab; 1991 Jan; 17(6):362-8. PubMed ID: 1823385
    [Abstract] [Full Text] [Related]

  • 24. Effect of clonidine on the progression of chronic renal disease in partially nephrectomized rats.
    Wilke WL, Fettman MJ, Tan AA.
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):161-72. PubMed ID: 2821594
    [Abstract] [Full Text] [Related]

  • 25. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
    Kanno Y, Okada H, Saruta T, Suzuki H.
    Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
    [Abstract] [Full Text] [Related]

  • 26. Manidipine attenuates a progressive renal injury in remnant kidneys of rats.
    Kobayashi S, Hishida A.
    Blood Press Suppl; 1992 Nov; 3():80-4. PubMed ID: 1343296
    [Abstract] [Full Text] [Related]

  • 27. Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys.
    Kobayashi S, Hishida A.
    J Lab Clin Med; 1995 May; 125(5):572-80. PubMed ID: 7738423
    [Abstract] [Full Text] [Related]

  • 28. Renoprotective effect of nisoldipine in rats with severe hypertension.
    Ishimitsu T, Ono H, Ogawa Y, Tsukada H, Oka K, Yagi S.
    J Hypertens; 1994 Jul; 12(7):751-9. PubMed ID: 7963503
    [Abstract] [Full Text] [Related]

  • 29. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
    Karasawa A, Kubo K, Oka T, Nakamizo N.
    Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
    [Abstract] [Full Text] [Related]

  • 30. Anti-proteinuric effect of an N-type calcium channel blocker, cilnidipine.
    Tsuchihashi T, Ueno M, Tominaga M, Kajioka T, Onaka U, Eto K, Goto K.
    Clin Exp Hypertens; 2005 Nov; 27(8):583-91. PubMed ID: 16303635
    [Abstract] [Full Text] [Related]

  • 31. Effect of propranolol on progression of chronic renal disease in partially nephrectomized rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):3-13. PubMed ID: 3671878
    [Abstract] [Full Text] [Related]

  • 32. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [Abstract] [Full Text] [Related]

  • 33. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats.
    Podjarny E, Hasdan G, Bernheim J, Rashid G, Green J, Korzets Z, Bernheim J.
    Nephrol Dial Transplant; 2004 Sep; 19(9):2223-7. PubMed ID: 15252157
    [Abstract] [Full Text] [Related]

  • 34. Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes.
    Jara A, Chacón C, Ibaceta M, Valdivieso A, Felsenfeld AJ.
    Nephrol Dial Transplant; 2004 Aug; 19(8):1986-92. PubMed ID: 15173378
    [Abstract] [Full Text] [Related]

  • 35. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Aug; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 36. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Aug; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 37. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
    Barenbrock M, Colmorgen U, Firschka E, Gellert J, Lippert J, Schröder K, Spieker C, Voigt-Ladner G, Wagner K, Neumayer HH.
    Clin Nephrol; 1995 Jun; 43(6):388-91. PubMed ID: 7554523
    [Abstract] [Full Text] [Related]

  • 38. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C, Golub MS, Eggena P, Barrett JD, Sambhi MP.
    J Cardiovasc Pharmacol; 1984 Jun; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [Abstract] [Full Text] [Related]

  • 39. Effect of the calcium channel blocker nisoldipine on the progression of chronic renal failure in man.
    Eliahou HE, Cohen D, Hellberg B, Ben-David A, Herzog D, Shechter P, Kapuler S, Kogan N.
    Am J Nephrol; 1988 Jun; 8(4):285-90. PubMed ID: 3189422
    [Abstract] [Full Text] [Related]

  • 40. Calcium channel blocker nisoldipine limits ischemic damage in rat kidney.
    Hertle L, Garthoff B.
    J Urol; 1985 Dec; 134(6):1251-4. PubMed ID: 4057426
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.